NASDAQ:KRYS | Free Cash Flow | Krystal Biotech, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2016-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$80.38M$7.15M$73.23M130.93%
2025-12-31$77.51M$2.14M$75.37M146.63%
2025-03-31$30.97M$6.2M$24.77M69.31%
2024-12-31$52.84M$801,000.00$52.04M114.43%
2024-03-31$15.89M$1.26M$14.63M1569.53%
2023-12-31-$7.23M$1.85M-$9.08M-104.45%
2023-03-31-$26.16M$5.38M-$31.54M
2022-12-31-$22.33M$5.22M-$27.55M
2022-03-31-$15.49M$17.19M-$32.68M
2021-12-31-$20.9M$40.88M-$61.78M
2021-03-31-$9.65M$2.47M-$12.13M
2020-12-31-$8.02M$7.21M-$15.23M
2020-03-31-$6.23M$1.51M-$7.74M
2019-12-31-$7M$2.28M-$9.28M
2019-03-31-$3.22M$1.71M-$4.92M
2018-12-31-$3.52M$1.3M-$4.82M
2018-03-31-$2.37M
2017-12-31-$2.13M$159,000.00-$2.29M
2017-03-31-$257,000.00$7,000.00-$264,000.00
2016-12-31-$861,000.00$9,000.00-$870,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$200.87M$11.95M$188.91M92.23%
2024-12-31$123.42M$4.24M$119.18M133.67%
2023-12-31-$88.8M$11.8M-$100.6M-920.26%
2022-12-31-$100.57M$52.98M-$153.55M
2021-12-31-$47.94M$68.34M-$116.27M
2020-12-31-$26.08M$14.84M-$40.93M
2019-12-31-$18.69M$6.4M-$25.09M
2018-12-31-$9.45M$2.23M-$11.68M
2017-12-31-$3.89M$210,000.00-$4.1M
2016-12-31-$1.31M$15,000.00-$1.33M